Elevated intracellular calcium in neutrophils in patients with Down syndrome

Background:  Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca2+i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study...

Full description

Saved in:
Bibliographic Details
Published inPediatrics international Vol. 51; no. 4; pp. 474 - 477
Main Authors Yamato, Fumiko, Takaya, Junji, Yasuhara, Akihiro, Teraguchi, Masayuki, Ikemoto, Yumiko, Kaneko, Kazunari
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.08.2009
Blackwell Publishing Ltd
Subjects
Online AccessGet full text
ISSN1328-8067
1442-200X
1442-200X
DOI10.1111/j.1442-200X.2008.02761.x

Cover

Abstract Background:  Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca2+i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca2+]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca2+]i regulation in neutrophils. Methods:  The study group consisted of 27 subjects with DS (age, 8.6 ± 4.6 years) and 14 healthy subjects (age, 12.0 ± 3.9 years). Using a fluorescent probe, fura‐2, the baseline levels and changes in [Ca2+]i were examined after stimulation of neutrophils with N‐formyl‐methionyl‐leucyl‐phenylalanine (fMLP). Results:  At baseline, the [Ca2+]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6  ±  28.0  nmol/L vs 44.4 ± 16.0 nmol/L, P < 0.01). The absolute [Ca2+]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 ± 91 nmol/L vs 167 ± 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects. Conclusions:  The higher [Ca2+]i and the prolonged response of [Ca2+]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.
AbstractList Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca(2+)i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca(2+)]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca(2+)]i regulation in neutrophils.BACKGROUNDNeutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca(2+)i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca(2+)]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca(2+)]i regulation in neutrophils.The study group consisted of 27 subjects with DS (age, 8.6 +/- 4.6 years) and 14 healthy subjects (age, 12.0 +/- 3.9 years). Using a fluorescent probe, fura-2, the baseline levels and changes in [Ca(2+)]i were examined after stimulation of neutrophils with N-formyl-methionyl-leucyl-phenylalanine (fMLP).METHODSThe study group consisted of 27 subjects with DS (age, 8.6 +/- 4.6 years) and 14 healthy subjects (age, 12.0 +/- 3.9 years). Using a fluorescent probe, fura-2, the baseline levels and changes in [Ca(2+)]i were examined after stimulation of neutrophils with N-formyl-methionyl-leucyl-phenylalanine (fMLP).At baseline, the [Ca(2+)]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6 +/- 28.0 nmol/L vs 44.4 +/- 16.0 nmol/L, P < 0.01). The absolute [Ca(2+)]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 +/- 91 nmol/L vs 167 +/- 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects.RESULTSAt baseline, the [Ca(2+)]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6 +/- 28.0 nmol/L vs 44.4 +/- 16.0 nmol/L, P < 0.01). The absolute [Ca(2+)]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 +/- 91 nmol/L vs 167 +/- 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects.The higher [Ca(2+)]i and the prolonged response of [Ca(2+)]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.CONCLUSIONSThe higher [Ca(2+)]i and the prolonged response of [Ca(2+)]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.
Background:  Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca 2+ i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca 2+ ]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca 2+ ]i regulation in neutrophils. Methods:  The study group consisted of 27 subjects with DS (age, 8.6 ± 4.6 years) and 14 healthy subjects (age, 12.0 ± 3.9 years). Using a fluorescent probe, fura‐2, the baseline levels and changes in [Ca 2+ ]i were examined after stimulation of neutrophils with N ‐formyl‐methionyl‐leucyl‐phenylalanine (fMLP). Results:  At baseline, the [Ca 2+ ]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6  ±  28.0  nmol/L vs 44.4 ± 16.0 nmol/L, P < 0.01). The absolute [Ca 2+ ]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 ± 91 nmol/L vs 167 ± 60 nmol/L, respectively: P  < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects. Conclusions:  The higher [Ca 2+ ]i and the prolonged response of [Ca 2+ ]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.
Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca(2+)i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca(2+)]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca(2+)]i regulation in neutrophils. The study group consisted of 27 subjects with DS (age, 8.6 +/- 4.6 years) and 14 healthy subjects (age, 12.0 +/- 3.9 years). Using a fluorescent probe, fura-2, the baseline levels and changes in [Ca(2+)]i were examined after stimulation of neutrophils with N-formyl-methionyl-leucyl-phenylalanine (fMLP). At baseline, the [Ca(2+)]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6 +/- 28.0 nmol/L vs 44.4 +/- 16.0 nmol/L, P < 0.01). The absolute [Ca(2+)]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 +/- 91 nmol/L vs 167 +/- 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects. The higher [Ca(2+)]i and the prolonged response of [Ca(2+)]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.
Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca2+i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca2+]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca2+]i regulation in neutrophils. The study group consisted of 27 subjects with DS (age, 8.6 ± 4.6 years) and 14 healthy subjects (age, 12.0 ± 3.9 years). Using a fluorescent probe, fura-2, the baseline levels and changes in [Ca2+]i were examined after stimulation of neutrophils with N -formyl-methionyl-leucyl-phenylalanine (fMLP). At baseline, the [Ca2+]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6 ± 28.0 nmol/L vs 44.4 ± 16.0 nmol/L, P < 0.01). The absolute [Ca2+]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 ± 91 nmol/L vs 167 ± 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects. The higher [Ca2+]i and the prolonged response of [Ca2+]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS. [PUBLICATION ABSTRACT]
Background:  Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca2+i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca2+]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca2+]i regulation in neutrophils. Methods:  The study group consisted of 27 subjects with DS (age, 8.6 ± 4.6 years) and 14 healthy subjects (age, 12.0 ± 3.9 years). Using a fluorescent probe, fura‐2, the baseline levels and changes in [Ca2+]i were examined after stimulation of neutrophils with N‐formyl‐methionyl‐leucyl‐phenylalanine (fMLP). Results:  At baseline, the [Ca2+]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6  ±  28.0  nmol/L vs 44.4 ± 16.0 nmol/L, P < 0.01). The absolute [Ca2+]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 ± 91 nmol/L vs 167 ± 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects. Conclusions:  The higher [Ca2+]i and the prolonged response of [Ca2+]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.
AbstractBackground: Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular calcium (Ca2+i) acts as a second messenger and regulates diverse functions in many cell types. The purpose of the present study was to compare the intracellular calcium concentration ([Ca2+]i) at baseline and stimulated conditions in DS patients and in normal subjects to investigate [Ca2+]i regulation in neutrophils.Methods: The study group consisted of 27 subjects with DS (age, 8.6 plus or minus 4.6 years) and 14 healthy subjects (age, 12.0 plus or minus 3.9 years). Using a fluorescent probe, fura-2, the baseline levels and changes in [Ca2+]i were examined after stimulation of neutrophils with N-formyl-methionyl-leucyl-phenylalanine (fMLP).Results: At baseline, the [Ca2+]i of neutrophils from DS subjects was significantly higher than that of the controls (70.6 plus or minus 28.0 nmol/L vs 44.4 plus or minus 16.0 nmol/L, P < 0.01). The absolute [Ca2+]i after addition of fMLP in the DS subjects was also significantly higher than that of the control group (250 plus or minus 91 nmol/L vs 167 plus or minus 60 nmol/L, respectively: P < 0.01). The neutrophils from the DS subjects had a consistently and significantly prolonged response to fMLP as compared to the neutrophils of control subjects.Conclusions: The higher [Ca2+]i and the prolonged response of [Ca2+]i to fMLP appear to be phenotypic traits of neutrophils in subjects with DS. This suggests intrinsic cellular defects in DS.
Author Takaya, Junji
Yamato, Fumiko
Yasuhara, Akihiro
Ikemoto, Yumiko
Teraguchi, Masayuki
Kaneko, Kazunari
Author_xml – sequence: 1
  givenname: Fumiko
  surname: Yamato
  fullname: Yamato, Fumiko
  organization: Department of Pediatrics, Kansai Medical University, Osaka, Japan
– sequence: 2
  givenname: Junji
  surname: Takaya
  fullname: Takaya, Junji
  organization: Department of Pediatrics, Kansai Medical University, Osaka, Japan
– sequence: 3
  givenname: Akihiro
  surname: Yasuhara
  fullname: Yasuhara, Akihiro
  organization: Department of Pediatrics, Kansai Medical University, Osaka, Japan
– sequence: 4
  givenname: Masayuki
  surname: Teraguchi
  fullname: Teraguchi, Masayuki
  organization: Department of Pediatrics, Kansai Medical University, Osaka, Japan
– sequence: 5
  givenname: Yumiko
  surname: Ikemoto
  fullname: Ikemoto, Yumiko
  organization: Department of Pediatrics, Kansai Medical University, Osaka, Japan
– sequence: 6
  givenname: Kazunari
  surname: Kaneko
  fullname: Kaneko, Kazunari
  organization: Department of Pediatrics, Kansai Medical University, Osaka, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19400826$$D View this record in MEDLINE/PubMed
BookMark eNqNUUmPFCEYJWaMs-hfMBUPeqoatgLqoImZ7lmSHnXieiMUUBnaWlqg7O5_P5Q904c5qBw-HvDeA753DA76obcAZAgWKI3TZYEoxTmG8EeRiigg5gwVmyfgaH9wkDDBIheQ8UNwHMISJiYX9Bk4RBVNGLMjsJi39reK1mSuj15p27Zjq3ymVavd2KXdrLdj9MPq1rVhWq5UdLaPIVu7eJvNhnWfhW1v_NDZ5-Bpo9pgX9zPJ-Dr-fzL2WW--HhxdfZ-kWsqBMqJLpmxiprKmFrXiPOmIayxpqqbRkOIRWM0qllZk6rmphKV0RVNmGrI0w45AW92vis__BptiLJzYXq66u0wBskJqVgpGE3M139lYsghoiVLxFePiMth9H36hcQIU4EFndxe3pPGurNGrrzrlN_Kh3YmwrsdQfshBG8bqV1M_Rqm3rpWIiin_ORSTjHJKaapCPknP7lJBuKRwf6Of0vf7qRr19rtf-vkp_lsQkmf7_QuRLvZ65X_KRknvJTfP1zIz9f8283sEssbcgfrVMH0
CitedBy_id crossref_primary_10_1371_journal_pone_0175437
crossref_primary_10_3389_fimmu_2021_621440
crossref_primary_10_3389_fimmu_2018_03058
crossref_primary_10_1016_j_jaci_2014_07_015
crossref_primary_10_1186_s10020_018_0004_y
crossref_primary_10_1111_imr_13296
crossref_primary_10_1093_hmg_dds529
crossref_primary_10_4236_ojpsych_2013_32A004
Cites_doi 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.0.CO;2-4
10.1152/physrev.1993.73.3.547
10.2223/JPED.966
10.4049/jimmunol.170.1.64
10.1016/S0021-9258(19)83641-4
10.1002/neu.480230915
10.1203/00006450-198409000-00024
10.1002/mrdd.1025
10.1016/S0531-5565(01)00179-6
10.1016/S0006-2952(01)00588-3
10.1016/S0022-3476(75)80077-1
10.4049/jimmunol.125.4.1665
10.1016/S0022-1759(99)00167-2
10.1111/j.1365-2249.1997.505-ce1403.x
10.1001/jama.240.8.737b
10.1007/BF00858987
ContentType Journal Article
Copyright 2008 Japan Pediatric Society
Journal compilation © 2009 Japan Pediatric Society
Copyright_xml – notice: 2008 Japan Pediatric Society
– notice: Journal compilation © 2009 Japan Pediatric Society
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U9
H94
K9.
7QP
7T5
7X8
DOI 10.1111/j.1442-200X.2008.02761.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Virology and AIDS Abstracts
Neurosciences Abstracts
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
AIDS and Cancer Research Abstracts

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1442-200X
EndPage 477
ExternalDocumentID 1805357541
19400826
10_1111_j_1442_200X_2008_02761_x
PED2761
ark_67375_WNG_SM7VQDH2_Q
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Feature
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29O
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AHMBA
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ESX
WRC
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U9
H94
K9.
7QP
7T5
7X8
ID FETCH-LOGICAL-c4881-3c56dea4d9ddbcb177ff36fed9bffc0028fdc1b65b39b7d989dc9439b4c079b73
IEDL.DBID DR2
ISSN 1328-8067
1442-200X
IngestDate Fri Jul 11 12:12:49 EDT 2025
Thu Jul 10 23:43:13 EDT 2025
Fri Oct 03 07:21:04 EDT 2025
Mon Jul 21 05:56:05 EDT 2025
Wed Oct 01 02:26:55 EDT 2025
Thu Apr 24 22:58:00 EDT 2025
Wed Jan 22 17:05:16 EST 2025
Sun Sep 21 06:18:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4881-3c56dea4d9ddbcb177ff36fed9bffc0028fdc1b65b39b7d989dc9439b4c079b73
Notes ark:/67375/WNG-SM7VQDH2-Q
ArticleID:PED2761
istex:0BFE756A28A9CB7DB1BBACDDE9B78B04EFA7680B
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 19400826
PQID 212482844
PQPubID 31868
PageCount 4
ParticipantIDs proquest_miscellaneous_733965864
proquest_miscellaneous_20701456
proquest_journals_212482844
pubmed_primary_19400826
crossref_citationtrail_10_1111_j_1442_200X_2008_02761_x
crossref_primary_10_1111_j_1442_200X_2008_02761_x
wiley_primary_10_1111_j_1442_200X_2008_02761_x_PED2761
istex_primary_ark_67375_WNG_SM7VQDH2_Q
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-08
August 2009
2009-08-00
2009-Aug
20090801
PublicationDateYYYYMMDD 2009-08-01
PublicationDate_xml – month: 08
  year: 2009
  text: 2009-08
PublicationDecade 2000
PublicationPlace Melbourne, Australia
PublicationPlace_xml – name: Melbourne, Australia
– name: Australia
– name: Tokyo
PublicationTitle Pediatrics international
PublicationTitleAlternate Pediatr Int
PublicationYear 2009
Publisher Blackwell Publishing Asia
Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Asia
– name: Blackwell Publishing Ltd
References Hallett MB, Hodges R, Cadman M et al. Techniques for measuring and manipulating free Ca2+ in the cytosol and organelles of neutrophils. J. Immunol. Methods 1999; 232: 77-88.
Proesmans W, De Cock P, Eyskens. A toddler with Down syndrome, hypercalcaemia, hypercalciuria, medullary nephrocalcinosis and renal failure. Pediatr. Nephrol. 1995; 9: 112-14.
Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A. Presenility of granulocytes in Down syndrome individuals. Am. J. Med. Genet. 1999; 84: 406-12.
Tam CF, Walford RL. Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome. J. Immunol. 1980; 125: 1665-70.
Choi DW. Excitoxic cell death. J. Neurobiol. 1992; 23: 1261-76.
Tintinger GR, Theron AJ, Anderson R, Ker JA. The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium. Biochem. Pharmacol. 2001; 61: 1319-28.
Anderson R, Goolam Mahomed A. Calcium efflux and influx in f-met-leu-phe(fMLP)-activated human neutrophils are chronologically distinct events. Clin. Exp. Immunol. 1997; 110: 132-8.
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985; 260: 3440-50.
Klut ME, Ruehlmann DO, Li L, Whalen BA, Van Breemen C, Hogg JC. Age-related changes in the calcium homeostasis of adherent neutrophils. Exp. Gerontol. 2002; 37: 533-41.
Scharff O, Foder B. Regulation of cytosolic calcium in blood cells. Physiol. Rev. 1993; 73: 547-82.
Lott IT, Head E. Down syndrome and Alzheimer's disease: A link between development and aging. Ment. Retard. Dev. Disabil. Res. Rev. 2001; 7:172-8.
Cocchi P, Silenzi M, Ravina A. Neutrophil viability in Down's syndrome. JAMA 1978; 240: 737.
Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 1985; 119: 101-10.
Andrei LK, Howard RP. Intracellular calcium waves accompany neutrophil polarization, formylmethionylleucylphenylalanine stimulation, and phagocytosis: A high speed microscopy study. J. Immunol. 2003; 170: 64-72.
Barkin RM, Weston WL, Humbert JR, Maire F. Phagocytic function in Down syndrome. Chemotaxis. J. Ment. Defic. Res. 1980; 24: 243-9.
Ribeiro LM, Jacob CM, Pastorino AC, Kim CA, Fomin AB, Castro AP. Evaluation of factors associated with recurrent and/or severe infections in patients with Down's syndrome. J. Pediatr. (Rio. J.) 2003; 79: 141-8.
McCoy EE, Sneddon JM. Decreased calcium content and 45 Ca2+ uptake in Down's syndrome blood platelets. Pediatr. Res. 1984; 18: 914-16.
Barkin RM, Weston WL, Humbert JR, Sunada K. Phagocytic function in Down syndrome. Bactericidal activity and phagocytosis. J. Ment. Defic. Res. 1980; 24: 251-6.
Khan AJ, Evans HE, Glass L, Skin YH, Almonte D. Defective neutrophil chemotaxis in patients with Down syndrome. J. Pediatr. 1975; 87: 87-9.
1995; 9
2001; 61
2002; 37
1993; 73
2001; 7
1980; 24
1997; 110
2003; 79
1978; 240
2003; 170
1984; 18
1999; 232
1999; 84
1975; 87
1985; 119
1985; 260
1992; 23
1980; 125
e_1_2_6_20_2
Haslett C (e_1_2_6_9_2) 1985; 119
e_1_2_6_8_2
Tam CF (e_1_2_6_12_2) 1980; 125
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_4_2
e_1_2_6_3_2
Barkin RM (e_1_2_6_6_2) 1980; 24
e_1_2_6_5_2
e_1_2_6_13_2
e_1_2_6_2_2
e_1_2_6_10_2
e_1_2_6_11_2
Barkin RM (e_1_2_6_7_2) 1980; 24
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
References_xml – reference: Lott IT, Head E. Down syndrome and Alzheimer's disease: A link between development and aging. Ment. Retard. Dev. Disabil. Res. Rev. 2001; 7:172-8.
– reference: Choi DW. Excitoxic cell death. J. Neurobiol. 1992; 23: 1261-76.
– reference: Scharff O, Foder B. Regulation of cytosolic calcium in blood cells. Physiol. Rev. 1993; 73: 547-82.
– reference: McCoy EE, Sneddon JM. Decreased calcium content and 45 Ca2+ uptake in Down's syndrome blood platelets. Pediatr. Res. 1984; 18: 914-16.
– reference: Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985; 260: 3440-50.
– reference: Ribeiro LM, Jacob CM, Pastorino AC, Kim CA, Fomin AB, Castro AP. Evaluation of factors associated with recurrent and/or severe infections in patients with Down's syndrome. J. Pediatr. (Rio. J.) 2003; 79: 141-8.
– reference: Hallett MB, Hodges R, Cadman M et al. Techniques for measuring and manipulating free Ca2+ in the cytosol and organelles of neutrophils. J. Immunol. Methods 1999; 232: 77-88.
– reference: Barkin RM, Weston WL, Humbert JR, Maire F. Phagocytic function in Down syndrome. Chemotaxis. J. Ment. Defic. Res. 1980; 24: 243-9.
– reference: Anderson R, Goolam Mahomed A. Calcium efflux and influx in f-met-leu-phe(fMLP)-activated human neutrophils are chronologically distinct events. Clin. Exp. Immunol. 1997; 110: 132-8.
– reference: Klut ME, Ruehlmann DO, Li L, Whalen BA, Van Breemen C, Hogg JC. Age-related changes in the calcium homeostasis of adherent neutrophils. Exp. Gerontol. 2002; 37: 533-41.
– reference: Andrei LK, Howard RP. Intracellular calcium waves accompany neutrophil polarization, formylmethionylleucylphenylalanine stimulation, and phagocytosis: A high speed microscopy study. J. Immunol. 2003; 170: 64-72.
– reference: Cocchi P, Silenzi M, Ravina A. Neutrophil viability in Down's syndrome. JAMA 1978; 240: 737.
– reference: Khan AJ, Evans HE, Glass L, Skin YH, Almonte D. Defective neutrophil chemotaxis in patients with Down syndrome. J. Pediatr. 1975; 87: 87-9.
– reference: Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A. Presenility of granulocytes in Down syndrome individuals. Am. J. Med. Genet. 1999; 84: 406-12.
– reference: Barkin RM, Weston WL, Humbert JR, Sunada K. Phagocytic function in Down syndrome. Bactericidal activity and phagocytosis. J. Ment. Defic. Res. 1980; 24: 251-6.
– reference: Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 1985; 119: 101-10.
– reference: Tam CF, Walford RL. Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome. J. Immunol. 1980; 125: 1665-70.
– reference: Tintinger GR, Theron AJ, Anderson R, Ker JA. The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium. Biochem. Pharmacol. 2001; 61: 1319-28.
– reference: Proesmans W, De Cock P, Eyskens. A toddler with Down syndrome, hypercalcaemia, hypercalciuria, medullary nephrocalcinosis and renal failure. Pediatr. Nephrol. 1995; 9: 112-14.
– volume: 240
  start-page: 737
  year: 1978
  article-title: Neutrophil viability in Down’s syndrome
  publication-title: JAMA
– volume: 125
  start-page: 1665
  year: 1980
  end-page: 70
  article-title: Alterations in cyclic nucleotides and cyclase‐specific activities in T lymphocytes of aging normal humans and patients with Down’s syndrome
  publication-title: J. Immunol
– volume: 37
  start-page: 533
  year: 2002
  end-page: 41
  article-title: Age‐related changes in the calcium homeostasis of adherent neutrophils
  publication-title: Exp. Gerontol
– volume: 24
  start-page: 243
  year: 1980
  end-page: 9
  article-title: Phagocytic function in Down syndrome
  publication-title: Chemotaxis. J. Ment. Defic. Res
– volume: 23
  start-page: 1261
  year: 1992
  end-page: 76
  article-title: Excitoxic cell death
  publication-title: J. Neurobiol
– volume: 170
  start-page: 64
  year: 2003
  end-page: 72
  article-title: Intracellular calcium waves accompany neutrophil polarization, formylmethionylleucylphenylalanine stimulation, and phagocytosis: A high speed microscopy study
  publication-title: J. Immunol
– volume: 18
  start-page: 914
  year: 1984
  end-page: 16
  article-title: Decreased calcium content and Ca uptake in Down’s syndrome blood platelets
  publication-title: Pediatr. Res
– volume: 84
  start-page: 406
  year: 1999
  end-page: 12
  article-title: Presenility of granulocytes in Down syndrome individuals
  publication-title: Am. J. Med. Genet
– volume: 9
  start-page: 112
  year: 1995
  end-page: 14
  article-title: Eyskens. A toddler with Down syndrome, hypercalcaemia, hypercalciuria, medullary nephrocalcinosis and renal failure
  publication-title: Pediatr. Nephrol
– volume: 73
  start-page: 547
  year: 1993
  end-page: 82
  article-title: Regulation of cytosolic calcium in blood cells
  publication-title: Physiol. Rev
– volume: 61
  start-page: 1319
  year: 2001
  end-page: 28
  article-title: The anti‐inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP‐mediated accelerated resequestration of cytosolic calcium
  publication-title: Biochem. Pharmacol
– volume: 79
  start-page: 141
  year: 2003
  end-page: 8
  article-title: Evaluation of factors associated with recurrent and/or severe infections in patients with Down’s syndrome
  publication-title: J. Pediatr. (Rio. J.)
– volume: 260
  start-page: 3440
  year: 1985
  end-page: 50
  article-title: A new generation of Ca indicators with greatly improved fluorescence properties
  publication-title: J. Biol. Chem
– volume: 87
  start-page: 87
  year: 1975
  end-page: 9
  article-title: Defective neutrophil chemotaxis in patients with Down syndrome
  publication-title: J. Pediatr
– volume: 110
  start-page: 132
  year: 1997
  end-page: 8
  article-title: Calcium efflux and influx in f‐met‐leu‐phe(fMLP)‐activated human neutrophils are chronologically distinct events
  publication-title: Clin. Exp. Immunol
– volume: 119
  start-page: 101
  year: 1985
  end-page: 10
  article-title: Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide
  publication-title: Am. J. Pathol
– volume: 232
  start-page: 77
  year: 1999
  end-page: 88
  article-title: Techniques for measuring and manipulating free Ca in the cytosol and organelles of neutrophils
  publication-title: J. Immunol. Methods
– volume: 24
  start-page: 251
  year: 1980
  end-page: 6
  article-title: Phagocytic function in Down syndrome. Bactericidal activity and phagocytosis
  publication-title: J. Ment. Defic. Res
– volume: 7
  start-page: 172
  year: 2001
  end-page: 8
  article-title: Down syndrome and Alzheimer’s disease: A link between development and aging
  publication-title: Ment. Retard. Dev. Disabil. Res. Rev
– ident: e_1_2_6_14_2
  doi: 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.0.CO;2-4
– volume: 24
  start-page: 251
  year: 1980
  ident: e_1_2_6_7_2
  article-title: Phagocytic function in Down syndrome. Bactericidal activity and phagocytosis
  publication-title: J. Ment. Defic. Res
– volume: 119
  start-page: 101
  year: 1985
  ident: e_1_2_6_9_2
  article-title: Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide
  publication-title: Am. J. Pathol
– ident: e_1_2_6_15_2
  doi: 10.1152/physrev.1993.73.3.547
– ident: e_1_2_6_2_2
  doi: 10.2223/JPED.966
– ident: e_1_2_6_5_2
  doi: 10.4049/jimmunol.170.1.64
– ident: e_1_2_6_10_2
  doi: 10.1016/S0021-9258(19)83641-4
– ident: e_1_2_6_20_2
  doi: 10.1002/neu.480230915
– ident: e_1_2_6_17_2
  doi: 10.1203/00006450-198409000-00024
– ident: e_1_2_6_19_2
  doi: 10.1002/mrdd.1025
– ident: e_1_2_6_18_2
  doi: 10.1016/S0531-5565(01)00179-6
– ident: e_1_2_6_13_2
  doi: 10.1016/S0006-2952(01)00588-3
– ident: e_1_2_6_3_2
  doi: 10.1016/S0022-3476(75)80077-1
– volume: 125
  start-page: 1665
  year: 1980
  ident: e_1_2_6_12_2
  article-title: Alterations in cyclic nucleotides and cyclase‐specific activities in T lymphocytes of aging normal humans and patients with Down’s syndrome
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.125.4.1665
– ident: e_1_2_6_4_2
  doi: 10.1016/S0022-1759(99)00167-2
– ident: e_1_2_6_11_2
  doi: 10.1111/j.1365-2249.1997.505-ce1403.x
– ident: e_1_2_6_8_2
  doi: 10.1001/jama.240.8.737b
– volume: 24
  start-page: 243
  year: 1980
  ident: e_1_2_6_6_2
  article-title: Phagocytic function in Down syndrome
  publication-title: Chemotaxis. J. Ment. Defic. Res
– ident: e_1_2_6_16_2
  doi: 10.1007/BF00858987
SSID ssj0008784
Score 1.8632543
Snippet Background:  Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The...
Background:  Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The...
Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to infection. The intracellular...
AbstractBackground: Neutrophils of patients with Down syndrome (DS) are known to have numerous abnormalities associated with diminished resistance to...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 474
SubjectTerms Adolescent
Calcium
Calcium - analysis
Calcium - physiology
Child
Child, Preschool
Down syndrome
Down Syndrome - metabolism
Female
Humans
intracellular calcium
Leukocytes
Male
neutrophil
Neutrophils - chemistry
Neutrophils - metabolism
Pediatrics
Title Elevated intracellular calcium in neutrophils in patients with Down syndrome
URI https://api.istex.fr/ark:/67375/WNG-SM7VQDH2-Q/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1442-200X.2008.02761.x
https://www.ncbi.nlm.nih.gov/pubmed/19400826
https://www.proquest.com/docview/212482844
https://www.proquest.com/docview/20701456
https://www.proquest.com/docview/733965864
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1328-8067
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1442-200X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0008784
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6hIiEuvB-mPPaAuDmyvZu1fURN2gjRigKF3Fb7sogSnCqJoeqvZ8bepE1VpApxs70Peb0zs9_sjr8BeItmsSp46uJUJzoWTmSx4dbHia58JnD9clXL9nkkRyfiw7g_DvFP9C9Mxw-x2XAjzWjtNSm4NssrSk6_liTJOIREZuiS9whPply23tXnCyapIi-6_LZZgUZZ5ttBPdd2tLVS3aaPfnYdDN1Gte2ytH8fpusBddEo016zMj17foXr8f-M-AHcC-iVve_E7SHc8vUjuHMYzucfw8fhzP9C9OrYhDaN6VSAwlwZCoKdND_xKat9s1rMT39MZku6DbyuS0Ybwmww_12zNYnCEzjZH37dG8UhX0Ns0QykMbd96bwWrnTOWOK1qiouK-9KU1WWvLvK2dTIvuGlyV1ZlM6WCIiMsEmOT_hT2KnntX8OzCNOMVJLxLMaPVwsTbLSEDlg5lzhdQT5em6UDWTmlFNjpi47NSKjLJvjkGqTPpY6iyDdtDztCD1u0OZdO_2bBnoxpYC4vK--Hx2oL4f5t-PBKFPHEeyu5UMFW7BUCA4E-rVCRPBmU4pKTHOgaz9vsAoa3hShbATsLzVyzommR2Inzzq5u3h7ym2PXmIEspWeGw9LfRoO6OrFvzbchbvd4RrFQ76EndWi8a8Qo63M61b7_gCRQywg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6hVgIuvCmmQPeAuDnyY7O2j4ikBEgiCi3kttqniBqcKomh4tczYzspqYpUIW629yGvd2b2m93xNwAv0Sz6PI1tGKtIhdzyJNSpcWGkvEs4rl_W12yfYzE44e8n3UmbDoj-hWn4ITYbbqQZtb0mBacN6UtaTv-WRNGkjYlM0CfvIKDc5QLdFkJIny64pPIsbzLcJjmaZZFth_Vc2dPWWrVLn_38KiC6jWvrhenwLszWQ2riUU471Up3zK9LbI__acz34E4LYNnrRuLuww1XPoCbo_aI_iEM-zP3AwGsZVPaN6aDAYp0ZSgLZlp9x6esdNVqMT_7Np0t6baldl0y2hNmvfnPkq15FB7ByWH_-M0gbFM2hAYtQRympiusU9wW1mpD1Fbep8I7W2jvDTl43ppYi65OC53ZIi-sKRATaW6iDJ-kj2GnnJfuCTCHUEULJRDSKnRysTRKCk38gIm1uVMBZOvJkablM6e0GjP5p1_DE0q0OWmzbdLHkucBxJuWZw2nxzXavKrnf9NALU4pJi7ryq_jt_LzKPty1Bsk8iiA_bWAyNYcLCXiA46uLecBHGxKUY9pDlTp5hVWQdsbI5oNgP2lRpamxNQjsJO9RvAu3p7S26OjGICoxefaw5If-z26evqvDQ_g1uB4NJTDd-MP-3C7OWuj8MhnsLNaVO45QraVflGr4m9oqTBB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6hVqq48IaaAt0D4ubIj_XriHBCgDZqgUJuK-9LRA1OlMRQ8euZsTcpqYpUIW629yGvd2b2m93xNwAv0SzaPA61H1ZB5XPNI1_GyvhBZU3Ecf3StmX7HKXDM_5-nIxdOiD6F6bjh9hsuJFmtPaaFNzMtb2i5fRvSRCMXUxkhD55DwHlLk-KnOL7yo-XXFJ5lncZbqMczXKabYf1XNvT1lq1S5_94joguo1r24VpcBem6yF18SjnvWYle-rXFbbH_zTme3DHAVj2upO4-3DL1A9g79gd0T-Eo_7U_EAAq9mE9o3pYIAiXRnKgpo03_Epq02zWszm3ybTJd06atcloz1hVs5-1mzNo_AIzgb9z2-GvkvZ4Cu0BKEfqyTVpuK60FoqorayNk6t0YW0VpGDZ7UKZZrIuJCZLvJCqwIxkeQqyPBJ_Bh26llt9oEZhCoyrVKEtBU6uVgaRIUkfsBI69xUHmTryRHK8ZlTWo2p-NOv4REl2hy7bJv0scSFB-Gm5bzj9LhBm1ft_G8aVItzionLEvF19FZ8Os6-nJbDSJx6cLAWEOHMwVIgPuDo2nLuweGmFPWY5qCqzazBKmh7Q0SzHrC_1MjimJh6UuzkSSd4l29P6e3RUfQgbcXnxsMSJ_2Srp7-a8ND2DspB-Lo3ejDAdzujtooOvIZ7KwWjXmOiG0lX7Sa-BvM6y_F
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+intracellular+calcium+in+neutrophils+in+patients+with+Down+syndrome&rft.jtitle=Pediatrics+international&rft.au=Yamato%2C+Fumiko&rft.au=Takaya%2C+Junji&rft.au=Yasuhara%2C+Akihiro&rft.au=Teraguchi%2C+Masayuki&rft.date=2009-08-01&rft.eissn=1442-200X&rft.volume=51&rft.issue=4&rft.spage=474&rft_id=info:doi/10.1111%2Fj.1442-200X.2008.02761.x&rft_id=info%3Apmid%2F19400826&rft.externalDocID=19400826
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1328-8067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1328-8067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1328-8067&client=summon